The biology and therapeutic management of melanoma brain metastases.

ABSTRACT: The recent years have seen significant progress in the development of systemic therapies to treat patients with advanced melanoma. Use of these new treatment modalities, which include immune checkpoint inhibitors and small molecule BRAF inhibitors, lead to increased overall survival and better outcomes. Although revolutionary, these therapies are often less effective against melanoma brain metastases, and frequently the CNS is the major site of treatment failure. The development of brain metastases remains a serious complication of advanced melanoma that is associated with significant morbidity and mortality. New approaches to both prevent the development of brain metastases and treat established disease are urgently needed. In this review we will outline the mechanisms underlying the deve

SUBMITTER: Abate-Daga D 

PROVIDER: S-EPMC5959746 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature